Press Releases

December 9, 2019 in Press Release

New Data Presented at the American Epilepsy Society Annual Meeting Demonstrate Unprecedented Efficacy Outcomes with the NeuroPace RNS System

Real-world experience with the RNS System reveals best outcomes to date of any neuromodulation device for focal seizures MOUNTAIN VIEW, Calif. — December 9, 2019 – NeuroPace, Inc. today announced that new data from a multicenter, real-world clinical study of the RNS System has demonstrated outcomes not previously seen with... Read More
December 4, 2019 in Press Release

Real-World Seizure Reduction Outcomes with the NeuroPace RNS System to be Presented at the American Epilepsy Society 2019 Annual Meeting

Presentations to include safety and efficacy outcomes for patients treated with brain-responsive neuromodulation MOUNTAIN VIEW, Calif. — December 2, 2019 – NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced that data from more than 30 studies of the RNS® System, the first and only closed-loop system for refractory focal... Read More
July 31, 2019 in Press Release

NeuroPace Appoints Mark Saxton as Vice President of Sales

Industry veteran to drive business development, strategy and enhance customer experience MOUNTAIN VIEW, Calif. — July 30, 2019 – NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced the appointment of Mark Saxton as the company’s Vice President of Sales. Mr. Saxton is an accomplished medical device industry executive... Read More
July 24, 2019 in Press Release

NeuroPace Announces Michael Favet as CEO

Frank Fischer appointed Chairman of Board of Directors MOUNTAIN VIEW, Calif. – July 24, 2019 (BUSINESS WIRE)–NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced the appointment of Michael Favet as Chief Executive Officer. Frank Fischer, after 20 years serving as CEO, continues with NeuroPace as Chairman of the…

Read More
July 10, 2019 in Press Release

NIH Study to Utilize NeuroPace RNS® System for Research on the Brain’s Reward System

Study Aims to Assess Whether Closed-Loop Neuromodulation Could Help Manage
 Medically Refractory Obesity MOUNTAIN VIEW, Calif. — July 10, 2019 – NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced that the company’s RNS® System, a closed-loop neuromodulation technology approved to treat adults with medically refractory focal onset epilepsy,... Read More
May 9, 2019 in Press Release

NeuroPace Shares Positive Data from Studies of the RNS System at the American Academy of Neurology 2019 Annual Meeting

Results Demonstrate Significant Seizure Reduction in Adults with Drug-Resistant Epilepsy; Insights into the Human Brain MOUNTAIN VIEW, Calif. — May 9, 2019 – NeuroPace, Inc., a Silicon Valley-based medical technology company, presented long-term clinical results demonstrating that the RNS® System for refractory epilepsy significantly reduces seizure frequency in patients, with... Read More